Skip to Main content Skip to Navigation
New interface
Journal articles

Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments

Abstract : Enterotoxigenic E. coli (ETEC) is a leading cause of moderate-to-severe diarrhoea. ETEC colonizes the intestine through fimbrial tip adhesin colonization factors and produces heat-stable and/or heat-labile (LT) toxins, stimulating fluid and electrolyte release leading to watery diarrhoea. We reported that a vaccine containing recombinant colonization factor antigen (CfaEB) targeting fimbrial tip adhesin of the colonization factor antigen I (CFA/I) and an attenuated LT toxoid (dmLT) elicited mucosal and systemic immune responses against both targets. Additionally, the toll-like receptor 4 ligand second-generation lipid adjuvant (TLR4-SLA) induced a potent mucosal response, dependent on adjuvant formulation. However, a combination of vaccine components at their respective individual optimal doses may not achieve the optimal immune profile. We studied a subunit ETEC vaccine prototype in mice using a response surface design of experiments (DoE), consisting of 64 vaccine dose-combinations of CfaEB, dmLT and SLA in four formulations (aqueous, aluminium oxyhydroxide, squalene-in-water stable nanoemulsion [SE] or liposomes containing the saponin Quillaja saponaria-21 [LSQ]). Nine readouts focusing on antibody functionality and plasma cell response were selected to profile the immune response of parenterally administered ETEC vaccine prototype. The data were integrated in a model to identify the optimal dosage of each vaccine component and best formulation. Compared to maximal doses used in mouse models (10 µg CfaEB, 1 µg dmLT and 5 µg SLA), a reduction in the vaccine components up to 37%, 60% and 88% for CfaEB, dmLT and SLA, respectively, maintained or even maximized immune responses, with SE and LSQ the best formulations. The DoE approach can help determine the best vaccine composition with a limited number of experiments and may accelerate development of multi-antigen/ component ETEC vaccines.
Keywords : Adjuvants
Document type :
Journal articles
Complete list of metadata
Contributor : Patricia BREMOND Connect in order to contact the contributor
Submitted on : Tuesday, March 9, 2021 - 7:52:54 AM
Last modification on : Wednesday, November 3, 2021 - 6:13:15 AM
Long-term archiving on: : Thursday, June 10, 2021 - 6:10:58 PM


Article Sergent M .pdf
Publisher files allowed on an open archive


Distributed under a Creative Commons Attribution 4.0 International License



David Poncet, Catherine Hessler, Hong Liang, Sylviane Gautheron, Michelle Sergent, et al.. Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments. NPJ vaccines, 2020, 5 (1), pp.83. ⟨10.1038/s41541-020-00228-w⟩. ⟨hal-03163022⟩



Record views


Files downloads